Envista Holdings Corp (STU:0HV)
€ 21 0 (0%) Market Cap: 3.63 Bil Enterprise Value: 4.18 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 73/100

Envista Holdings Corp at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 11:00PM GMT
Release Date Price: €21.97 (+3.15%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Perfect. Hello, everyone. Good afternoon. This is Rachel Vatnsdal with the life science tools and diagnostics team here at JPMorgan. Today, we're going to have Envista's presentation. As is typical with most of these breakout sessions that you've been in, it'll be 20 minutes of a presentation and then roughly 20 minutes of Q&A. So with that, I will invite Amir and Stephen up to the podium.

Amir Aghdaei
Envista Holdings Corporation - President, CEO & Director

Thanks for having us here. This is over 4 years since we have been independent as an independently publicly traded company. I wanted to give you a quick status update of our transformation, where we are and what to expect moving forward. You all are familiar with that. I'm not going to read it. Simply put, that we are keeping the 2023 guidance that we had provided before with us intact. We are working through it. It's been a challenging year. A lot happened during 2023. We've been able to manage through it. But when

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot